免疫学の世界市場

免疫学の世界市場は2030年までに1,544億米ドルに到達

2024年に1,135億米ドルと推定される免疫学の世界市場は、分析期間2024-2030年にCAGR 5.3％で成長し、2030年には1,544億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである診断検査機器は、CAGR 6.4%を記録し、分析期間終了時には880億米ドルに達すると予測されます。バイオマーカー分野の成長率は、分析期間中CAGR 3.6%と推定されます。

米国市場は309億米ドルと推定、中国はCAGR 8.6%で成長予測

米国の免疫学市場は、2024年に309億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに312億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは8.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.5％と5.3％と予測されています。欧州では、ドイツがCAGR 3.4%で成長すると予測されています。

世界の免疫学市場- 主要動向と促進要因のまとめ

なぜ免疫学が複雑な疾患の理解と治療の中心なのか？

免疫学-免疫系とその病原体、がん細胞、アレルゲン、体内調節異常に対する反応の研究-は、膨大な医学研究と治療開発の中核をなしています。この学問領域は感染症をはるかに超えて拡大し、現在では自己免疫、腫瘍学、移植生物学、神経炎症、慢性炎症性疾患を包含しています。プレシジョン・メディシンの台頭により、個々の免疫反応を理解することは、効果的な治療を行う上で不可欠となっています。

免疫学の進歩は、モノクローナル抗体、チェックポイント阻害剤、CAR-T細胞療法などの画期的な進歩を可能にしました。さらに、免疫調節剤やサイトカイン標的生物学的製剤は、関節リウマチ、乾癬、喘息、多発性硬化症などの治療に変革をもたらしつつあります。免疫学はまた、ワクチン開発、特に新興ウイルスの脅威や、免疫腫瘍学で開発中の治療用がんワクチンにも基礎となっています。

研究開発プラットフォームは、どのように免疫学のイノベーションを推進しているのか？

免疫学研究における技術革新は、シングルセル解析、フローサイトメトリー、次世代シークエンシング（NGS）、先進イメージングプラットフォームによって推進されています。これらのツールは、研究者がかつてない解像度で免疫系の挙動をマッピングし、免疫寛容、炎症、細胞媒介免疫のメカニズムを明らかにするのに役立っています。AIとバイオインフォマティクスは、免疫ゲノミクスと薬剤やワクチンに対する免疫反応の予測モデリングを加速させています。

製薬会社やバイオテクノロジー企業は、新規の生物製剤や細胞ベースの治療法を発見するために、免疫学に焦点を当てた研究開発に多額の投資を行っています。ヒト化マウスモデル、臓器オンチップ技術、個別化免疫プロファイリングは、試験管内で患者固有の免疫応答をシミュレートし研究するために使用されています。自己免疫疾患と免疫腫瘍学の臨床試験は、特にmAbs、チェックポイント阻害剤、二特異性T細胞エンゲイジャー（BiTEs）の治療パイプラインの成長を牽引し続けています。

免疫学的ソリューションが優先される疾患と市場は？

ループス、1型糖尿病、クローン病などの自己免疫疾患は、免疫チェックポイント阻害薬によく反応するメラノーマや非小細胞肺がんなどの、癌と並んで、免疫学的研究の主要分野です。アレルギー、喘息、移植拒絶反応もまた、免疫学に基づく介入によって対処される主要な治療領域です。さらに、神経免疫学への関心が高まっており、免疫応答とアルツハイマー病やパーキンソン病などの神経変性疾患との関連性が指摘されています。

北米は免疫学研究と治療開発でリードしており、学術研究拠点と強力なバイオ医薬品パイプラインに支えられています。欧州は、先進的な規制と臨床研究のエコシステムでこれに追随しています。アジア太平洋は、特に免疫療法開発とワクチン製造において、中国、インド、日本が主導して急速に成長しています。政府の支援による研究プログラム、生物製剤への投資、COVID-19の反動により、すべての主要地域で免疫学の活動が加速しています。

免疫学市場の成長はいくつかの要因によって牽引されている...

免疫学市場の成長は、自己免疫疾患や炎症性疾患の有病率の上昇、免疫測定プラットフォームや細胞分析における技術進歩、免疫調整薬の強力な治療パイプラインなど、いくつかの要因によって牽引されています。生物製剤開発、免疫チェックポイント阻害剤、精密標的治療が臨床的ブレークスルーを牽引しています。免疫学的研究開発への資金提供の増加、世界のワクチンの拡大、学界と産業界の連携が市場の勢いを強めています。

最終用途の観点からは、がん領域における免疫療法の需要拡大、自己免疫疾患における生物学的製剤の使用拡大、診断における免疫学的バイオマーカーの役割の拡大が重要な成長要因となっています。個別化医療の出現、ワクチンアジュバントの革新、微生物-免疫軸の幅広い理解もまた、長期的な産業拡大に寄与しています。免疫系が21世紀の医療の中心になるにつれ、世界の免疫学市場はイノベーション主導の持続的成長を遂げることになります。

セグメント

製品タイプ（診断検査機器、バイオマーカー、バイオ医薬品）、用途（アレルギー・過敏症、自己免疫疾患、感染症、HIV・エイズ、その他用途）、最終用途（病院・クリニック、製薬・バイオテクノロジー企業、診断研究所、その他最終用途）

調査対象企業の例（注目の32社）

• AbbVie Inc.
• Amgen Inc.
• Biogen Inc.
• Boehringer Ingelheim
• Bristol Myers Squibb
• Celltrion Healthcare Co., Ltd.
• Eli Lilly and Company
• F. Hoffmann-La Roche AG
• Gilead Sciences, Inc.
• GlaxoSmithKline plc
• Grifols S.A.
• Johnson & Johnson
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.
• UCB S.A.
• Vertex Pharmaceuticals Incorporated

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Immunology Market to Reach US$154.4 Billion by 2030

The global market for Immunology estimated at US$113.5 Billion in the year 2024, is expected to reach US$154.4 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Diagnostic Testing Equipment, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$88.0 Billion by the end of the analysis period. Growth in the Biomarkers segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$30.9 Billion While China is Forecast to Grow at 8.6% CAGR

The Immunology market in the U.S. is estimated at US$30.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$31.2 Billion by the year 2030 trailing a CAGR of 8.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Immunology Market - Key Trends & Drivers Summarized

Why Is Immunology Central to Understanding and Treating Complex Diseases?

Immunology-the study of the immune system and its response to pathogens, cancer cells, allergens, and internal dysregulation-is at the core of a vast range of medical research and therapeutic development. The discipline has expanded far beyond infectious disease and now encompasses autoimmunity, oncology, transplant biology, neuroinflammation, and chronic inflammatory diseases. With the rise of precision medicine, understanding individual immune responses has become critical to tailoring effective treatments.

Advancements in immunology have enabled breakthroughs such as monoclonal antibodies, checkpoint inhibitors, and CAR-T cell therapy. Additionally, immunomodulators and cytokine-targeting biologics are transforming the treatment of conditions like rheumatoid arthritis, psoriasis, asthma, and multiple sclerosis. Immunology is also foundational to vaccine development, particularly for emerging viral threats and for therapeutic cancer vaccines under development in immuno-oncology.

How Are Research and Drug Development Platforms Driving Immunology Innovation?

Technological innovation in immunology research is being driven by single-cell analysis, flow cytometry, next-generation sequencing (NGS), and advanced imaging platforms. These tools are helping researchers map immune system behavior at unprecedented resolution and uncover mechanisms of immune tolerance, inflammation, and cell-mediated immunity. AI and bioinformatics are accelerating immunogenomics and predictive modeling of immune responses to drugs and vaccines.

Pharmaceutical and biotech companies are investing heavily in immunology-focused R&D to discover novel biologics and cell-based therapies. Humanized mouse models, organ-on-chip technologies, and personalized immunoprofiling are being used to simulate and study patient-specific immune responses in vitro. Clinical trials in autoimmune diseases and immuno-oncology continue to drive therapeutic pipeline growth, particularly for mAbs, checkpoint inhibitors, and bispecific T-cell engagers (BiTEs).

Which Diseases and Markets Are Prioritizing Immunological Solutions?

Autoimmune diseases such as lupus, type 1 diabetes, and Crohn’s disease are key areas of immunological research, alongside cancers such as melanoma and non-small-cell lung cancer that respond well to immune checkpoint blockade. Allergies, asthma, and transplant rejection also represent major therapeutic areas addressed through immunology-based interventions. Additionally, emerging interest in neuroimmunology is linking immune responses to neurodegenerative disorders like Alzheimer’s and Parkinson’s.

North America leads in immunology research and therapeutic development, supported by academic research hubs and a strong biopharmaceutical pipeline. Europe follows closely with advanced regulatory and clinical research ecosystems. Asia-Pacific is rapidly growing, particularly in immunotherapy development and vaccine manufacturing, led by China, India, and Japan. Government-backed research programs, biologics investment, and the COVID-19 response have accelerated immunology activity across all major regions.

The Growth in the Immunology Market Is Driven by Several Factors…

The growth in the immunology market is driven by several factors including rising prevalence of autoimmune and inflammatory diseases, technological advances in immunoassay platforms and cellular analysis, and strong therapeutic pipelines for immune-modulating drugs. Biologics development, immune checkpoint inhibitors, and precision-targeted therapies are driving clinical breakthroughs. Increased funding for immunological R&D, global vaccine expansion, and partnerships between academia and industry are reinforcing market momentum.

From an end-use perspective, expanding demand for immunotherapy in oncology, increased use of biologics in autoimmune conditions, and the growing role of immunological biomarkers in diagnostics are key growth levers. The emergence of personalized immunology, innovations in vaccine adjuvants, and broader understanding of the microbiome-immune axis are also contributing to long-term industry expansion. As the immune system becomes central to 21st-century medicine, the global immunology market is set for sustained, innovation-led growth.

SCOPE OF STUDY:

The report analyzes the Immunology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Diagnostic Testing Equipment, Biomarkers, Biopharmaceuticals); Application (Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS, Other Applications); End-Use (Hospitals & Clinics, Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• AbbVie Inc.
• Amgen Inc.
• Biogen Inc.
• Boehringer Ingelheim
• Bristol Myers Squibb
• Celltrion Healthcare Co., Ltd.
• Eli Lilly and Company
• F. Hoffmann-La Roche AG
• Gilead Sciences, Inc.
• GlaxoSmithKline plc
• Grifols S.A.
• Johnson & Johnson
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.
• UCB S.A.
• Vertex Pharmaceuticals Incorporated

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Immunology - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Autoimmune and Inflammatory Diseases Fuels Research in Immunological Pathways
  • Biotech Innovation in Monoclonal Antibodies and Cytokine Inhibitors Accelerates Therapeutic Discovery
  • Growth in Immuno-Oncology Drives Breakthroughs in T-cell Modulation and Checkpoint Inhibition
  • Increased Focus on Vaccine Development Strengthens Investment in Adaptive and Innate Immune Mechanisms
  • Integration of AI and Systems Biology Enhances Immune Profiling and Personalized Immunology Research
  • Expansion of Microbiome-Immunity Studies Opens New Avenues for Probiotic-Based Immune Modulation
  • Emerging mRNA Technologies Support Development of Next-Gen Immune Therapies and Preventive Solutions
  • Rise in Cell and Gene Therapies Accelerates Need for Deep Immunological Characterization and Safety Assessment
  • Autoimmune Biomarker Discovery Fuels Early Diagnosis and Disease Monitoring Innovations
  • Growth in Allergen Immunotherapy and Desensitization Programs Expands Clinical Immunology Applications
  • Expansion of Immunology-Focused CRO Services Supports Outsourced Drug Discovery Workflows
  • Increased Emphasis on Maternal and Neonatal Immunology Enhances Pre/Postnatal Treatment Research
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Immunology Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Immunology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostic Testing Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Diagnostic Testing Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Diagnostic Testing Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Biopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Biopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Biopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Allergy & Hypersensitivity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Allergy & Hypersensitivity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Allergy & Hypersensitivity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Autoimmune Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Autoimmune Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Autoimmune Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Infectious Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for HIV & AIDS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for HIV & AIDS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for HIV & AIDS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Immunology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Immunology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Immunology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Immunology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Immunology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Immunology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Immunology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Immunology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Immunology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Immunology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Immunology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Immunology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Immunology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Immunology by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Immunology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Immunology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Immunology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Immunology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Immunology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Immunology by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Immunology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Immunology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Immunology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Immunology by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Immunology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Immunology by Product Type - Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Immunology by Product Type - Percentage Breakdown of Value Sales for Diagnostic Testing Equipment, Biomarkers and Biopharmaceuticals for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Immunology by End-Use - Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Immunology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Diagnostic Laboratories, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Immunology by Application - Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Immunology by Application - Percentage Breakdown of Value Sales for Allergy & Hypersensitivity, Autoimmune Disease, Infectious Disease, HIV & AIDS and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION